When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. New Drug Application - Wikipedia

    en.wikipedia.org/wiki/New_Drug_Application

    To legally test the drug on human subjects in the United States, the maker must first obtain an Investigational New Drug (IND) designation from FDA. [5] This application is based on nonclinical data, typically from a combination of in vivo and in vitro laboratory safety studies, that shows the drug is safe enough to test in humans. [5]

  3. Marketing authorisation - Wikipedia

    en.wikipedia.org/wiki/Marketing_authorisation

    The application dossier for marketing authorisation is called a New Drug Application (NDA) in the USA or Marketing Authorisation Application (MAA) in the European Union and other countries, or simply registration dossier. This contains data proving that the drug has quality, efficacy and safety properties suitable for the intended use ...

  4. Investigational New Drug - Wikipedia

    en.wikipedia.org/wiki/Investigational_new_drug

    The United States Food and Drug Administration's Investigational New Drug (IND) program is the means by which a pharmaceutical company obtains permission to start human clinical trials and to ship an experimental drug across state lines (usually to clinical investigators) before a marketing application for the drug has been approved.

  5. Marketing Authorisation Application - Wikipedia

    en.wikipedia.org/wiki/Marketing_authorisation...

    Marketing Authorisation Application (MAA) is an application submitted by a drug manufacturer seeking marketing authorisation, that is permission to bring a medicinal product (for example, a new medicine or generic medicine) to the market.

  6. Abbreviated New Drug Application - Wikipedia

    en.wikipedia.org/wiki/Abbreviated_New_Drug...

    An Abbreviated New Drug Application (ANDA) is an application for a U.S. generic drug approval for an existing licensed medication or approved drug. The ANDA is submitted to FDA's Center for Drug Evaluation and Research, Office of Generic Drugs, which provides for the review and ultimate approval of a generic drug product. Once approved, an ...

  7. Iovance Biotherapeutics Pushes FDA Rolling Submission ...

    www.aol.com/iovance-biotherapeutics-pushes-fda...

    As part of an amendment to the ongoing investigational new drug application submitted during Q3, Iovance received recent FDA feedback regarding supplemental assay validation information and ...

  8. Complete Response Letter - Wikipedia

    en.wikipedia.org/wiki/Complete_Response_Letter

    In United States pharmaceutical regulatory practice, a Complete Response Letter (CRL), or more rarely, a 314.110 letter, is a regulatory action by the Food and Drug Administration in response to a New Drug Application, Amended New Drug Application or Biologics License Application, indicating that the application will not be approved in its present form. [1]

  9. FDA to allow Florida to import prescription drugs in bulk ...

    www.aol.com/news/fda-allow-florida-import...

    The Food and Drug Administration said Friday it will allow Florida to buy prescription drugs directly from wholesalers in Canada, a move that is intended to lower the cost of prescription drugs ...